MIR103A2: A Potential Drug Target and Biomarker (G406896)

MIR103A2: A Potential Drug Target and Biomarker

MIR103A2, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and potential therapies to exploit its effects.

MIR103A2 is a small non-coding RNA molecule that is expressed in various tissues and cells in the body. It is composed of 292 amino acid residues and has a molecular weight of 30.9 kDa. MIR103A2 is primarily expressed in the brain and heart, and its levels are decreased in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

MIR103A2 has been shown to play a role in various biological processes, including cell growth, differentiation, and survival. It has been shown to promote the growth and survival of cancer cells, and it has been used as a potential cancer therapeutic. In addition, MIR103A2 has been linked to neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its levels have been shown to be decreased in these diseases, and MIR103A2 has been shown to promote the growth of neuroblastoma cells, which are a common type of neuro cancer.

In addition to its potential role in disease, MIR103A2 has also been shown to be a potential biomarker for various diseases, including cancer. Its levels have been shown to be decreased in various types of cancer, including breast, ovarian, and colorectal cancer. In addition, MIR103A2 has been shown to have a negative impact on cancer cell proliferation and migration.

MIR103A2's unique structure and function have made it an attractive target for researchers to investigate, and potential therapies to exploit its effects. One approach to targeting MIR103A2 is to use small molecules to inhibit its activity. Researchers have shown that inhibitors of MIR103A2 can effectively inhibit its activity in cell cultures and animal models of disease. These inhibitors have been shown to have potential as therapeutic agents for various diseases, including cancer.

Another approach to targeting MIR103A2 is to use antibodies to block its function. Researchers have shown that antibodies against MIR103A2 can effectively block its activity in cell cultures and animal models of disease. These antibodies have been shown to be effective in targeting and inhibiting MIR103A2 in various diseases.

MIR103A2 has also been shown to be a potential biomarker for various diseases, including cancer. Its levels have been shown to be decreased in various types of cancer, including breast, ovarian, and colorectal cancer. In addition, MIR103A2 has been shown to have a negative impact on cancer cell proliferation and migration. This makes it an attractive target for researchers to investigate and develop biomarkers for cancer diagnosis and treatment.

In conclusion, MIR103A2 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and potential therapies to exploit its effects. Further research is needed to fully understand the role of MIR103A2 in disease and to develop effective therapies to target its activity.

Protein Name: MicroRNA 103a-2

More Common Targets

MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A